Natus Medical NCFO Growth Trend

Natus Medical Incorporated -- USA Stock  

USD 28.65  0.4  1.42%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed NCFO Growth of Natus Medical Incorporated with missing and latest data points interpolated. Measures the growth in Net Cash Flow from Operations over the specified period.
NCFO Growth  10 Years Trend  
 NCFO Growth 

Natus Medical NCFO Growth Over Time

2016-12-31  0.18 
2017-12-31  0.18 
2018-12-31  0.030437 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  0.36
Geometric Mean  0.3
Coefficient Of Variation  226.42
Mean Deviation  0.62
Median  0.15
Standard Deviation  0.82
Sample Variance  0.67
Range  2.96
R Value (0.25)
Mean Square Error  0.69
R Squared  0.064349
Significance  0.4
Slope (0.053379)
Total Sum of Squares  8.06

Currently Trending

Purchased over 90 shares of
1 hour ago ago
Traded for 20.03
Purchased over 90 shares of
1 hour ago ago
Traded for 98.21
Purchased over 90 shares of
1 hour ago ago
Traded for 107.43